Reported Reactions

Devices › Implant, endosseous, root-form

Device brand name · Endosseous dental implant

NobelParallel CC TiUltra RP 4.3x18mm: medical device reports filed with FDA

624 reports name it, 2020–2026. Manufacturer given most often on reports: Nobel Biocare. Product code DZE.

624
device reports naming the brand
0% of all MAUDE reports · about 112 a year
126
reports, 12 months to August 2026
114 in the 12 months before
1.1%
classified as malfunction
0.8% across the product code
0%
classified as death, as reported
0 reports · not verified by FDA

624 medical device reports received by FDA name the brand "NobelParallel CC TiUltra RP 4.3x18mm" (endosseous dental implant); the manufacturer given most often on reports is Nobel Biocare; received from December 2020 to August 2026. Brand names are as the reporter or manufacturer wrote them, so one product can appear under several spellings.

126 reports arrived in the 12 months to August 2026, up 11% from 114 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (98.9%) and malfunction (1.1%); across all implant, endosseous, root-form reports (product code DZE) death is recorded in 0% and malfunction in 0.8%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are failure to osseointegrate (72.1%), loss of osseointegration (14.1%) and osseointegration problem (6.1%). The patient problems coded most often are failure of implant, pain and appropriate clinical signs, symptoms and conditions term/code not available. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

01836Sep 2021: 0Oct 2021: 6Nov 2021: 6Dec 2021: 122022Jan 2022: 18Feb 2022: 6Mar 2022: 18Apr 2022: 12May 2022: 14Jun 2022: 4Jul 2022: 2Aug 2022: 8Sep 2022: 4Oct 2022: 14Nov 2022: 2Dec 2022: 162023Jan 2023: 8Feb 2023: 4Mar 2023: 6Apr 2023: 14May 2023: 4Jun 2023: 2Jul 2023: 25Aug 2023: 3Sep 2023: 16Oct 2023: 4Nov 2023: 12Dec 2023: 142024Jan 2024: 6Feb 2024: 6Mar 2024: 16Apr 2024: 0May 2024: 18Jun 2024: 8Jul 2024: 10Aug 2024: 14Sep 2024: 12Oct 2024: 12Nov 2024: 8Dec 2024: 42025Jan 2025: 6Feb 2025: 10Mar 2025: 6Apr 2025: 0May 2025: 0Jun 2025: 0Jul 2025: 36Aug 2025: 20Sep 2025: 14Oct 2025: 16Nov 2025: 2Dec 2025: 62026Jan 2026: 6Feb 2026: 32Mar 2026: 4Apr 2026: 10May 2026: 14Jun 2026: 4Jul 2026: 10Aug 2026: 8

Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

By year received

0591182020: 420202021: 7220212022: 11820222023: 11220232024: 11420242025: 11620252026: 882026

Event type and report source

Event type, as classified on the report

Death0%0
Injury98.9%617
Malfunction1.1%7
Other0%0
Not given0%0

Who filed the report

Manufacturer report50%312
Voluntary report0%0
User facility report0%0
Distributor report50%312
Not given0%0

Grey bar: all 3,924,241 reports carrying product code DZE. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Failure to osseointegrate45072.1%62.8%
Loss of osseointegration8814.1%22.4%
Osseointegration problem386.1%7.7%
Fracturea broken bone182.9%1.6%
Patient device interaction problem40.6%0.3%
Premature separation40.6%0.1%
Difficult to insertthe device was hard to insert20.3%0.4%
Flaked20.3%0%
Malposition of device20.3%0.1%
Migrationthe device moved from where it was placed20.3%0.1%
Separation failure20.3%0.1%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
Failure of implant43068.9%
Painpain, site not specified609.6%
Appropriate clinical signs, symptoms and conditions term/code not available182.9%
Numbnessnumbness121.9%
Inflammationinflammation61%
Bone fracture(s)40.6%
Implant pain40.6%
Osteomyelitis20.3%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureNobelParallel CC TiUltra RP 4.3x18mmProduct code DZEAll MAUDE reports
Reports6243,924,24126,136,888
Share of that pool—0%0%
Classified as death, per 1,000 reports009
Classified as injury98.9%99.2%36.2%
Classified as malfunction1.1%0.8%62.3%
Filed by the manufacturer50%77.7%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code DZE

BrandReportsLatest 12 monthsClassified as death
Biohorizons Dental Implant58,73200%
BioHorizons Inc.57,02025,5360%
NobelActive Internal RP 4.3x10mm49,0989,5280%
BLT ?4.1mm RC, SLA? 10mm, TiZr, Loxim45,6509,6770%
NobelParallel CC RP 4.3x10mm44,2699,3180%
BLT ?4.1mm RC, SLActive? 10mm, TiZr, NTP41,6727,5310%
Unknown Implant39,9671,4540%
NobelReplace CC RP 4.3x10mm35,9468,1660%
NobelReplace CC PMC RP 4.3x10mm34,4478,6900%
NobelActive Internal RP 4.3x11.5mm33,1175,7040%
BLT ?3.3mm NC, SLA? 10mm, TiZr, Loxim28,6485,6950%
BLT ?4.1mm RC, SLA? 10mm, Ti, Loxim26,7248,4810%
BLT ?3.3mm NC, SLActive? 10mm, TiZr, NTP26,5404,6800%
NobelActive Internal RP 4.3x13mm25,5563,7640%
BLT ?4.1mm RC, SLA? 8mm, TiZr, Loxim24,7725,9780%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about NobelParallel CC TiUltra RP 4.3x18mm reports

How many FDA reports name NobelParallel CC TiUltra RP 4.3x18mm?

624 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 126 in the latest 12 months.

What kinds of events are reported?

injury (98.9%) and malfunction (1.1%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

failure to osseointegrate (72.1%), loss of osseointegration (14.1%), osseointegration problem (6.1%), fracture (2.9%) and patient device interaction problem (0.6%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (50%) and distributor reports (50%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that NobelParallel CC TiUltra RP 4.3x18mm was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.